CAS No. 1186486-62-3
| IUPAC Name | 4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid | |
|---|---|---|
| CAS Number | 1186486-62-3 | |
| Molecular Formula |
C31H36F6N6O2 |
|
| Molecular Weight (MW) | 638.65 | |
| SMILES | CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C | |
| InChIKey | IHIUGIVXARLYHP-UXNJHFGPSA-N |
Evacetrapib (LY2484595) is a potent inhibitor of cholesteryl ester transfer protein (CETP). By inhibiting CETP activity, it suppresses the transfer of cholesteryl esters from high-density lipoprotein (HDL) to pro-atherogenic lipoproteins, leading to elevated HDL cholesterol levels and apolipoprotein A-I concentrations. Furthermore, evacetrapib produces targeted CETP inhibition without inducing adverse increases in aldosterone secretion or blood pressure. [1][2]
|
Concentration
Volume
Mass
|
|---|
| Solvent | Solubility & Note |
|---|---|
| DMSO |
12.8 mg/mL
(20.04 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 12.8 mg/mL |
| Water | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- Evacetrapib (LY2484595) Clinical Trials
- Evacetrapib (LY2484595) Solubility in DMSO
- Evacetrapib (LY2484595) Stock Solution
- Evacetrapib (LY2484595) Storage
- Evacetrapib (LY2484595) Stability
- Evacetrapib (LY2484595) Molecular Weight
- Evacetrapib (LY2484595) SMILES
- Evacetrapib (LY2484595) Chemical Structure (2D and 3D)
- Evacetrapib (LY2484595) SDS|MSDS